Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma.
Saved in:
| Title: | Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma. |
|---|---|
| Authors: | Naghavi, A.O.1 (AUTHOR), Costello, J.2 (AUTHOR), Kim, Y.3 (AUTHOR), Joyce, D.4 (AUTHOR), Ahmed, K.A.5 (AUTHOR), Redler, G.1 (AUTHOR), Yang, G.Q.1 (AUTHOR), Rosenberg, S.A.1 (AUTHOR), Bryant, J.M.1 (AUTHOR), Bui, M.M.6 (AUTHOR), Henderson-Jackson, E.B.6 (AUTHOR), Gonzalez, R.J.4 (AUTHOR), Binitie, O.4 (AUTHOR), Lazarides, A.4 (AUTHOR), Mullinax, J.4 (AUTHOR), Feygelman, V.1 (AUTHOR), Ahmed, A.F.2 (AUTHOR), Parikh, N.2 (AUTHOR), Torres-Roca, J.F.1 (AUTHOR), Latifi, K.1 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS88-S89. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03603016 |
|---|---|
| DOI: | 10.1016/j.ijrobp.2024.07.156 |
